Cargando…

A molecule inducing androgen receptor degradation and selectively targeting prostate cancer cells

Aberrant androgen signaling drives prostate cancer and is targeted by drugs that diminish androgen production or impede androgen–androgen receptor (AR) interaction. Clinical resistance arises from AR overexpression or ligand-independent constitutive activation, suggesting that complete AR eliminatio...

Descripción completa

Detalles Bibliográficos
Autores principales:	Auvin, Serge, Öztürk, Harun, Abaci, Yusuf T, Mautino, Gisele, Meyer-Losic, Florence, Jollivet, Florence, Bashir, Tarig, de Thé, Hugues, Sahin, Umut
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Life Science Alliance LLC 2019
Materias:	Research Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6703138/ https://www.ncbi.nlm.nih.gov/pubmed/31431473 http://dx.doi.org/10.26508/lsa.201800213

Ejemplares similares

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Tax as a therapeutic target in ATL
por: Dassouki, Zeina, et al.
Publicado: (2015)

Oxidative stress–induced assembly of PML nuclear bodies controls sumoylation of partner proteins
por: Sahin, Umut, et al.
Publicado: (2014)

Androgen receptor isoforms expression in benign prostatic hyperplasia and primary prostate cancer
por: Hillebrand, Ana Caroline, et al.
Publicado: (2018)

Structural insights reveal a recognition feature for tailoring hydrocarbon stapled-peptides against the eukaryotic translation initiation factor 4E protein
por: Lama, Dilraj, et al.
Publicado: (2019)

Human SP-D Acts as an Innate Immune Surveillance Molecule Against Androgen-Responsive and Androgen-Resistant Prostate Cancer Cells
por: Thakur, Gargi, et al.
Publicado: (2019)

Androgen Mediated Regulation of Endoplasmic Reticulum-Associated Degradation and its Effects on Prostate Cancer
por: Erzurumlu, Yalcin, et al.
Publicado: (2017)

Effect of Small Molecules Modulating Androgen Receptor (SARMs) in Human Prostate Cancer Models
por: Tesei, Anna, et al.
Publicado: (2013)

Small Molecule Antagonists of the Nuclear Androgen Receptor for the Treatment of Castration-Resistant Prostate Cancer
por: Johnson, James K., et al.
Publicado: (2016)

Inhibition of androgen receptor by decoy molecules delays progression to castration-recurrent prostate cancer
por: Myung, Jae-Kyung, et al.
Publicado: (2017)

Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate Cancer
por: Fu, Weitao, et al.
Publicado: (2023)

Androgens and prostate disease
por: Cooper, Lori A, et al.
Publicado: (2014)

SIRNA-Directed In Vivo Silencing of Androgen Receptor Inhibits the Growth of Castration-Resistant Prostate Carcinomas
por: Compagno, Daniel, et al.
Publicado: (2007)

Retinoids Regulate the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer Cells
por: Kelsey, Linda, et al.
Publicado: (2012)

Androgen receptor degraders overcome common resistance mechanisms developed during prostate cancer treatment
por: Kregel, Steven, et al.
Publicado: (2020)

Selective androgen receptor degrader (SARD) to overcome antiandrogen resistance in castration-resistant prostate cancer
por: Wu, Meng, et al.
Publicado: (2023)

Biological and Clinical Significance of Androgens and Androgen Receptor in Prostate Cancer
por: Koochekpour, Shahriar
Publicado: (2014)

Androgen resistance in prostate cancer
por: Waxman, J, et al.
Publicado: (2008)

Androgens, aging, and prostate health
por: Welén, Karin, et al.
Publicado: (2022)

Carbidopa suppresses prostate cancer via aryl hydrocarbon receptor-mediated ubiquitination and degradation of androgen receptor
por: Chen, Zhiwei, et al.
Publicado: (2020)

Hedgehog/Gli supports androgen signaling in androgen deprived and androgen independent prostate cancer cells
por: Chen, Mengqian, et al.
Publicado: (2010)

Mapping the Interactions between a RUN Domain from DENND5/Rab6IP1 and Sorting Nexin 1
por: Fernandes, Humberto, et al.
Publicado: (2012)

Tasquinimod modulates tumor-infiltrating myeloid cells and improves the antitumor immune response to PD-L1 blockade in bladder cancer
por: Nakhlé, Jessica, et al.
Publicado: (2016)

NTSR1 glycosylation and MMP dependent cleavage generate three distinct forms of the protein
por: Libanje, Fotine, et al.
Publicado: (2023)

On the Choice of Longitudinal Models for the Analysis of Antitumor Efficacy in Mouse Clinical Trials of Patient-derived Xenograft Models
por: Savel, Hélène, et al.
Publicado: (2023)

Identification of Comamonas testosteroni as an androgen degrader in sewage
por: Chen, Yi-Lung, et al.
Publicado: (2016)

Androgens as therapy for androgen receptor-positive castration-resistant prostate cancer
por: Chuu, Chih-Pin, et al.
Publicado: (2011)

The Androgen Receptor and VEGF: Mechanisms of Androgen-Regulated Angiogenesis in Prostate Cancer
por: Eisermann, Kurtis, et al.
Publicado: (2017)

Response to Androgens and Androgen Receptor Antagonists in the Presence of Cytokines in Prostate Cancer
por: Culig, Zoran
Publicado: (2021)

Androgen Metabolism and Response in Prostate Cancer Anti-Androgen Therapy Resistance
por: Zhang, Haozhe, et al.
Publicado: (2022)

Food components and contaminants as (anti)androgenic molecules
por: Marcoccia, Daniele, et al.
Publicado: (2017)

Vitamin D(3) Regulates the Formation and Degradation of Gap Junctions in Androgen-Responsive Human Prostate Cancer Cells
por: Kelsey, Linda, et al.
Publicado: (2014)

Equol inhibits prostate cancer growth through degradation of androgen receptor by S‐phase kinase‐associated protein 2
por: Itsumi, Momoe, et al.
Publicado: (2016)

Comparison of the Anti-Tumour Activity of the Somatostatin Receptor (SST) Antagonist [(177)Lu]Lu-Satoreotide Tetraxetan and the Agonist [(177)Lu]Lu-DOTA-TATE in Mice Bearing AR42J SST(2)-Positive Tumours
por: Plas, Pascale, et al.
Publicado: (2022)

Overexpression of Endothelial Cell-Specific Molecule 1 Correlates with Gleason Score and Expression of Androgen Receptor in Prostate Carcinoma
por: Lai, Chung-Yu, et al.
Publicado: (2017)

Androgen deprivation and cognition in prostate cancer
por: Salminen, E, et al.
Publicado: (2003)

Hormones and prostate carcinogenesis: Androgens and estrogens
por: Bosland, Maarten C., et al.
Publicado: (2011)

Mechanisms of Androgen-Independent Prostate Cancer
por: Saraon, Punit, et al.
Publicado: (2014)

Plasma Androgen Receptor in Prostate Cancer
por: Conteduca, Vincenza, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_m3d3infosqhm1a03r98jrrqgcc